The ALG9 gene helps cells add sugar chains to proteins, a basic step that lets many proteins fold and work properly. If it does not work well, the body may have trouble building and using proteins in many organs. Harmful variants in the ALG9 gene can cause a congenital disorder of glycosylation (a condition where cells do not attach sugars to proteins in the usual way), which may lead to developmental delay, low muscle tone, seizures, and problems affecting the kidneys, liver, heart, or other organs.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some provide the directions for producing proteins, which are the functional parts of cells. Others mainly help determine when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
ALG9Gene function
What if the gene works
The ALG9 gene helps cells build sugar chains that are attached to many proteins. This step supports proper protein folding and transport, especially in the cell’s protein-making area.
Risk
What if the gene does not work
More severe variants in the ALG9 gene can disrupt sugar tagging of proteins, causing ALG9-CDG with developmental delay, low muscle tone, seizures, and liver or kidney problems. Some milder or single copy variants are linked to liver or kidney cysts.
Treatment
What does that mean for your treatment
For pathogenic variants in the ALG9 gene, no ALG9-specific treatment or drug choice approach is currently established, and care is guided by the person’s symptoms and the organs affected.
Conditions associated with ALG9
Gene function
What if the gene works
Inside your cells, the ALG9 gene helps build sugar tags that are added to many newly made proteins. This work happens in the endoplasmic reticulum, the part of the cell that processes proteins. These sugar tags help proteins fold into the right shape and move through the cell in an organized way.
The ALG9 gene adds specific sugar units called mannose to a growing sugar chain. This chain is assembled on a fat-like carrier before it is placed onto proteins.
This sugar chain is then used for N-linked glycosylation, a normal step that attaches sugar tags to many proteins. This is a central part of ALG9 gene function in protein glycosylation.
By helping build the right sugar tag, the ALG9 gene supports protein folding and quality checks in the endoplasmic reticulum (the cell’s protein-processing area). This helps many proteins mature and move to the right place.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and form part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to, or in some cases cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALG9 gene can change the shape or stability of its protein, so cells make fewer complete sugar chains during glycosylation (the process of attaching sugar chains to proteins). Some ALG9 gene variants leave partial activity, while more disruptive variants can greatly reduce or stop this step. That difference in functional impact may help explain why ALG9-CDG can vary, with milder changes sometimes linked to less pronounced features and more severe changes to earlier or broader effects.
How variants are linked to conditions
Pathogenic variants in the ALG9 gene can cause ALG9-CDG, a rare inherited condition that often begins in infancy and may involve developmental delay, low muscle tone, seizures, liver problems, and growth concerns. This diagnosis is usually confirmed when disease-causing variants are found in both copies of the ALG9 gene. Conditions linked to ALG9 gene variants also include polycystic liver disease, sometimes with kidney cysts, in some families carrying a single variant.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the general population. Most do not directly affect health and instead represent normal human diversity. In many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors also contribute. At times, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ALG9 gene. Personal risk usually depends most on the exact gene change and family history, so anyone with concerns should speak with a doctor or genetic counselor.
Inheritance of ALG9 variants
For the well-established condition linked to the ALG9 gene, inheritance follows an autosomal recessive pattern. This means a child usually inherits one ALG9 variant from each parent, and the parents are often healthy carriers. When both parents carry an ALG9 variant, each pregnancy has a 25% chance of the child inheriting both changed copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how ALG9 gene variants are inherited depends on whether one or both copies of the gene are changed in a family.
What does my ALG9 result mean for my family?
What this means for family members depends on which ALG9-related condition the result is tied to. For the rare childhood condition caused by changes in both copies of ALG9, parents are usually healthy carriers, and brothers, sisters, and other relatives may also be carriers or, less often, affected. For the liver cyst condition linked to a change in one copy of ALG9, close relatives may also carry the same change and could consider discussing family testing.
Genetic information
Genetic testing
How you find out about variants
Variants in the ALG9 gene are found with genetic testing for ALG9 variants, usually using a blood sample, saliva sample, or cheek swab. A lab reads the gene’s DNA letters and compares them with the usual sequence, then reports whether a variant was found and whether it is known to be benign, uncertain, or linked to disease.
When should I consider getting a genetic test?
Consider genetic testing if a child has signs of a rare inherited condition linked to the ALG9 gene, such as developmental delay, low muscle tone, seizures, or multiple liver or kidney cysts, especially when there is a family history. Testing can also help clarify risk when a close relative has a known change in the ALG9 gene.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but what it reveals depends on the condition and the specific type of variant. How the body works over time is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, cause more side effects in another, or seem to have less effect in someone else. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a drug. These differences are common and are one of several factors, along with age, other health conditions, and other medicines, that can shape treatment response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. By looking at links between genes and drugs, it helps explain why treatments may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ALG9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so questions about side effects, new symptoms, or treatment changes are best discussed with your doctor. If you are worried that a medicine is causing problems, seek medical advice promptly.
History
Researchers first identified the ALG9 gene through studies of how cells build sugar chains that are attached to proteins. Initially understood only through visible traits, later recognized as tied to a specific gene, ALG9 was mapped as part of the larger group of ALG genes involved in this pathway. Work in yeast helped show that the ALG9 gene makes an enzyme needed for one step in assembling these sugar chains in the cell’s protein-making system. Building on this early work, scientists later linked changes in the human ALG9 gene to a rare inherited condition in the congenital disorders of glycosylation group. That discovery connected basic laboratory research with a specific human condition and clarified the gene’s medical importance.